| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.0M | +254.7% |
| R&D Expense | $116.6M | +42.1% |
| SG&A Expense | $73.5M | +118.2% |
| Operating Income | -$190.8M | -66.4% |
| Income Tax | -$270K | — |
| Net Income | -$161.0M | -82.9% |
| EPS (Basic) | -$2.08 | -47.5% |
| EPS (Diluted) | -$2.08 | -47.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.5M | -87.4% |
| Short-term Investments | $709.7M | +46.3% |
| Accounts Receivable | $688K | — |
| Inventory | $1.6M | — |
| Current Assets | $759.5M | +0.7% |
| Total Assets | $791.6M | +4.9% |
| Current Liabilities | $30.8M | +44.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$132.3M | -68.1% |
| Capital Expenditures | $134K | -42.7% |
| Investing Cash Flow | -$245.8M | +18.3% |
| Financing Cash Flow | $153.6M | -75.6% |
| Free Cash Flow | -$132.5M | -67.8% |
| Long-term Debt |
| $3.0M |
| — |
| Total Liabilities | $39.0M | +82.0% |
| Stockholders' Equity | $752.6M | +2.6% |